can semaglutide cause pots Dr. Tania Dempsey on GLP-1s for MCAS, and related conditions Unleashing the Power of Semaglutide:

QD community oral or SC MOTS-c Daily SC, often 5 days on / 2 off AOD-9604 Daily SC Attribute Max studied dose SLU-PP-332 50 mg/kg BID (mouse, 28 days) MOTS-c 5-15 mg/kg (mouse) AOD-9604 1-5 mg/day in human Phase 2 Attribute Peak efficacy signal SLU-PP-332 ~25-30% fat-mass reduction in DIO mice over 28 days MOTS-c Improved insulin sensitivity in aged mice AOD-9604 Modest fat-loss signal in human Phase 2

What is Ileus

The frequency of use will depend on the individual's needs and the advice of a healthcare provider

In chronic pain populations, these therapies can be effective components of a multimodal strategy, but are generally most appropriate for patients with identifiable neuropathology rather than centrally mediated pain [70]

Combating oxidative stress and neuroinflammation